[{"address1": "14191 Myford Road", "city": "Tustin", "state": "CA", "zip": "92780", "country": "United States", "phone": "714-508-6100", "website": "https://www.avidbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.", "fullTimeEmployees": 365, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nicholas Stewart Green B.Sc., MBA", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1349656, "exercisedValue": 0, "unexercisedValue": 404625}, {"maxAge": 1, "name": "Mr. Daniel R. Hart", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 719746, "exercisedValue": 33350, "unexercisedValue": 2175295}, {"maxAge": 1, "name": "Mr. Richard  Richieri", "age": 58, "title": "Chief Operations Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 561681, "exercisedValue": 0, "unexercisedValue": 687515}, {"maxAge": 1, "name": "Mr. Mark R. Ziebell J.D.", "age": 59, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 647101, "exercisedValue": 64601, "unexercisedValue": 1976741}, {"maxAge": 1, "name": "Mr. Matthew  Kwietniak", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 553586, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Oksana  Lukash", "title": "Vice President of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 2, "shareHolderRightsRisk": 4, "overallRisk": 3, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.71, "open": 6.65, "dayLow": 6.48, "dayHigh": 6.77, "regularMarketPreviousClose": 6.71, "regularMarketOpen": 6.65, "regularMarketDayLow": 6.48, "regularMarketDayHigh": 6.77, "beta": 1.653, "forwardPE": -216.66667, "volume": 2044110, "regularMarketVolume": 2044110, "averageVolume": 1575150, "averageVolume10days": 2731090, "averageDailyVolume10Day": 2731090, "bid": 6.01, "ask": 6.83, "bidSize": 3200, "askSize": 1400, "marketCap": 411054784, "fiftyTwoWeekLow": 4.07, "fiftyTwoWeekHigh": 21.05, "priceToSalesTrailing12Months": 2.9165647, "fiftyDayAverage": 6.9264, "twoHundredDayAverage": 9.48795, "currency": "USD", "enterpriseValue": 576327040, "profitMargins": -0.08124, "floatShares": 58371081, "sharesOutstanding": 63239200, "sharesShort": 6593041, "sharesShortPriorMonth": 5229426, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.1043, "heldPercentInsiders": 0.01045, "heldPercentInstitutions": 0.91989, "shortRatio": 6.81, "shortPercentOfFloat": 0.1245, "impliedSharesOutstanding": 65282400, "bookValue": 2.905, "priceToBook": 2.2375216, "lastFiscalYearEnd": 1682812800, "nextFiscalYearEnd": 1714435200, "mostRecentQuarter": 1698710400, "netIncomeToCommon": -11450000, "trailingEps": -0.18, "forwardEps": -0.03, "pegRatio": -1.66, "lastSplitFactor": "1:7", "lastSplitDate": 1499644800, "enterpriseToRevenue": 4.089, "enterpriseToEbitda": -1150.353, "52WeekChange": -0.65407133, "SandP52WeekChange": 0.30583346, "lastDividendValue": 0.656, "lastDividendDate": 1521158400, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CDMO", "underlyingSymbol": "CDMO", "shortName": "Avid Bioservices, Inc.", "longName": "Avid Bioservices, Inc.", "firstTradeDateEpochUtc": 765466200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a0fc0136-42be-36de-81a3-35bc25628d0f", "messageBoardId": "finmb_189510", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.5, "targetHighPrice": 16.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.25, "targetMedianPrice": 13.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 31424000, "totalCashPerShare": 0.497, "ebitda": -501000, "totalDebt": 196696000, "quickRatio": 0.723, "currentRatio": 1.354, "totalRevenue": 140938000, "debtToEquity": 107.089, "revenuePerShare": 2.246, "returnOnAssets": -0.0135699995, "returnOnEquity": -0.06276, "freeCashflow": -52683752, "operatingCashflow": 1705000, "revenueGrowth": -0.269, "grossMargins": 0.12524, "ebitdaMargins": -0.0035499998, "operatingMargins": -0.44189999, "financialCurrency": "USD", "trailingPegRatio": null}]